Clinical Microbiology and Antimicrobial Chemotherapy. 2019; 21(4):282-309
Polymyxins are often the only agents that remain in vitro active against extensively resistant bacterial pathogens. However, the use of polymyxins is compromised by the number of unresolved issues, including the technical aspects of antimicrobial …